Logo image of CTAC.AS

CTAC NV (CTAC.AS) Stock Fundamental Analysis

Europe - AMS:CTAC - NL0000345577 - Common Stock

3.36 EUR
+0.01 (+0.3%)
Last: 10/24/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, CTAC scores 5 out of 10 in our fundamental rating. CTAC was compared to 73 industry peers in the IT Services industry. Both the profitability and the financial health of CTAC get a neutral evaluation. Nothing too spectacular is happening here. CTAC is valued quite cheap, while showing a decent growth score. This is a good combination! CTAC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CTAC had positive earnings in the past year.
In the past year CTAC had a positive cash flow from operations.
Each year in the past 5 years CTAC has been profitable.
Each year in the past 5 years CTAC had a positive operating cash flow.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

The Return On Assets of CTAC (5.74%) is better than 65.75% of its industry peers.
CTAC has a Return On Equity (13.36%) which is comparable to the rest of the industry.
CTAC has a worse Return On Invested Capital (7.06%) than 60.27% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CTAC is significantly below the industry average of 20.36%.
Industry RankSector Rank
ROA 5.74%
ROE 13.36%
ROIC 7.06%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of CTAC (3.28%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CTAC has grown nicely.
CTAC has a Operating Margin of 4.54%. This is comparable to the rest of the industry: CTAC outperforms 41.10% of its industry peers.
CTAC's Operating Margin has improved in the last couple of years.
CTAC has a Gross Margin (54.86%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CTAC has declined.
Industry RankSector Rank
OM 4.54%
PM (TTM) 3.28%
GM 54.86%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

CTAC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CTAC has about the same amount of shares outstanding.
CTAC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CTAC has been reduced compared to a year ago.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.02 indicates that CTAC is not in any danger for bankruptcy at the moment.
CTAC has a Altman-Z score of 3.02. This is in the better half of the industry: CTAC outperforms 65.75% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that CTAC is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.37, CTAC perfoms like the industry average, outperforming 57.53% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 3.02
ROIC/WACC1.06
WACC6.64%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.00 indicates that CTAC should not have too much problems paying its short term obligations.
The Current ratio of CTAC (1.00) is worse than 61.64% of its industry peers.
A Quick Ratio of 1.00 indicates that CTAC should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.00, CTAC is in line with its industry, outperforming 41.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

6

3. Growth

3.1 Past

CTAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 351.71%, which is quite impressive.
CTAC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.20% yearly.
Looking at the last year, CTAC shows a small growth in Revenue. The Revenue has grown by 0.81% in the last year.
CTAC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.74% yearly.
EPS 1Y (TTM)351.71%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%15.97%
Revenue 1Y (TTM)0.81%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%1.44%

3.2 Future

Based on estimates for the next years, CTAC will show a very strong growth in Earnings Per Share. The EPS will grow by 21.55% on average per year.
The Revenue is expected to grow by 7.12% on average over the next years.
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y5.84%
Revenue Next 5Y7.12%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

CTAC is valuated reasonably with a Price/Earnings ratio of 11.59.
Compared to the rest of the industry, the Price/Earnings ratio of CTAC indicates a rather cheap valuation: CTAC is cheaper than 84.93% of the companies listed in the same industry.
CTAC is valuated cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.84, the valuation of CTAC can be described as very cheap.
89.04% of the companies in the same industry are more expensive than CTAC, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.92. CTAC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.59
Fwd PE 7.84
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTAC indicates a rather cheap valuation: CTAC is cheaper than 84.93% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.8
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

CTAC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTAC's earnings are expected to grow with 21.55% in the coming years.
PEG (NY)0.25
PEG (5Y)0.48
EPS Next 2Y30.93%
EPS Next 3Y21.55%

7

5. Dividend

5.1 Amount

CTAC has a Yearly Dividend Yield of 3.28%.
Compared to an average industry Dividend Yield of 3.97, CTAC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, CTAC pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.28%

5.2 History

On average, the dividend of CTAC grows each year by 17.13%, which is quite nice.
Dividend Growth(5Y)17.13%
Div Incr Years0
Div Non Decr Years1
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

37.91% of the earnings are spent on dividend by CTAC. This is a low number and sustainable payout ratio.
The dividend of CTAC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP37.91%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

CTAC NV

AMS:CTAC (10/24/2025, 7:00:00 PM)

3.36

+0.01 (+0.3%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.93%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap47.54M
Revenue(TTM)125.22M
Net Income(TTM)4.10M
Analysts85
Price Target3.83 (13.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.28%
Yearly Dividend0.11
Dividend Growth(5Y)17.13%
DP37.91%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.59
Fwd PE 7.84
P/S 0.38
P/FCF N/A
P/OCF 20.26
P/B 1.55
P/tB 11.14
EV/EBITDA 4.8
EPS(TTM)0.29
EY8.63%
EPS(NY)0.43
Fwd EY12.75%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.17
OCFY4.94%
SpS8.85
BVpS2.17
TBVpS0.3
PEG (NY)0.25
PEG (5Y)0.48
Graham Number3.76
Profitability
Industry RankSector Rank
ROA 5.74%
ROE 13.36%
ROCE 15.2%
ROIC 7.06%
ROICexc 7.47%
ROICexgc 21.3%
OM 4.54%
PM (TTM) 3.28%
GM 54.86%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
ROICexc(3y)9.86%
ROICexc(5y)10.11%
ROICexgc(3y)93.05%
ROICexgc(5y)116.82%
ROCE(3y)14.76%
ROCE(5y)14.73%
ROICexgc growth 3Y-10.84%
ROICexgc growth 5Y39.25%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y15.11%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
F-Score5
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 1.02
Cap/Depr 69.4%
Cap/Sales 2.97%
Interest Coverage 14.65
Cash Conversion 21.25%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 3.02
F-Score5
WACC6.64%
ROIC/WACC1.06
Cap/Depr(3y)40.73%
Cap/Depr(5y)30.86%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.4%
Profit Quality(3y)401.58%
Profit Quality(5y)373.89%
High Growth Momentum
Growth
EPS 1Y (TTM)351.71%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%15.97%
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue 1Y (TTM)0.81%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%1.44%
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y5.84%
Revenue Next 5Y7.12%
EBIT growth 1Y24.33%
EBIT growth 3Y-4.9%
EBIT growth 5Y21.94%
EBIT Next Year66.67%
EBIT Next 3Y25.99%
EBIT Next 5YN/A
FCF growth 1Y-114.47%
FCF growth 3Y-7.01%
FCF growth 5Y0.39%
OCF growth 1Y-79.51%
OCF growth 3Y2.52%
OCF growth 5Y4.91%

CTAC NV / CTAC.AS FAQ

What is the ChartMill fundamental rating of CTAC NV (CTAC.AS) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTAC.AS.


What is the valuation status of CTAC NV (CTAC.AS) stock?

ChartMill assigns a valuation rating of 7 / 10 to CTAC NV (CTAC.AS). This can be considered as Undervalued.


Can you provide the profitability details for CTAC NV?

CTAC NV (CTAC.AS) has a profitability rating of 5 / 10.


How financially healthy is CTAC NV?

The financial health rating of CTAC NV (CTAC.AS) is 4 / 10.


What is the expected EPS growth for CTAC NV (CTAC.AS) stock?

The Earnings per Share (EPS) of CTAC NV (CTAC.AS) is expected to grow by 46.94% in the next year.